Antihypertensive action of allantoin in animals

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Mei Fen ^a,b   Tsai, Jo Ting ^c   Chen, Li Jen ^d   Wu, Tung Pi ^e   Yang, Jia Jang ^b   Yin, Li Te ^b   Yang, Yu Lin ^b   Chiang, Tai An ^b   Lu, Han Lin ^e   Wu, Ming Chang ^a  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e TAINAN SIN LAU HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; EFAROXAN; GUANIDINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; ANTIHYPERTENSIVE AGENT; IMIDAZOLINE I1 RECEPTORS; IMIDAZOLINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DEPRESSED BLOOD PRESSURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERIPHERAL CIRCULATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE; AGONISTS; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; HEART CONTRACTION; HYPERTENSION; PATHOPHYSIOLOGY; WISTAR RAT;

ALLANTOIN; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HEART RATE; HYPERTENSION; IMIDAZOLINE RECEPTORS; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 84897476889     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/690135     Document Type: Article

References (35)

1. van Zwieten P. A., Chalmers J. P., Different types of centrally acting antihypertensives and their targets in the central nervous system. Cardiovascular Drugs and Therapy 1994 8 6 787 799 2-s2.0-0028643651 10.1007/BF00877397
2. Chalmers J., Pilowsky P., Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. Journal of Hypertension 1991 9 8 675 694 2-s2.0-0025745348
3. Sagara K., Ojima M., Suto K., Yoshida T., Quantitative determination of allantoin in Dioscorea rhizome and an oriental pharmaceutical preparation, Hachimi-Gan, by high-performance liquid chromatography. Planta Medica 1989 55 1 93 2-s2.0-0024602301 (Pubitemid 19058365)
4. Shestopalov A. V., Shkurat T. P., Mikashinovich Z. I., Kryzhanovskaia I. O., Bogacheva M. A., Lomteva S. V., Prokof'ev V. P., Gus'kov E. P., Biological functions of allantoin. Izvestiya Akademii Nauk 2006 5 541 545 2-s2.0-39049186158
5. Sato K., Iemitsu M., Aizawa K., Ajisaka R., DHEA improves impaired activation of Akt and PKC ζ / -GLUT4 pathway in skeletal muscle and improves hyperglycaemia in streptozotocin-induced diabetes rats. Acta Physiologica 2009 197 3 217 225 2-s2.0-70350506321 10.1111/j.1748-1716.2009. 02011.x
6. Gao X., Li B., Jiang H., Liu F., Xu D., Liu Z., Dioscorea opposita reverses dexamethasone induced insulin resistance. Fitoterapia 2007 78 1 12 15 2-s2.0-33845398363 10.1016/j.fitote.2006.09.015 (Pubitemid 44909357)
7. Hsu J.-H., Wu Y.-C., Liu I.-M., Cheng J.-T., Dioscorea as the principal herb of Die-Huang-Wan, a widely used herbal mixture in China, for improvement of insulin resistance in fructose-rich chow-fed rats. Journal of Ethnopharmacology 2007 112 3 577 584 2-s2.0-34347388209 10.1016/j.jep.2007.05.013 (Pubitemid 47023038)
8. Shujun W., Hongyan L., Wenyuan G., Haixia C., Jiugao Y., Peigen X., Characterization of new starches separated from different Chinese yam (Dioscorea opposita Thunb.) cultivars. Food Chemistry 2006 99 1 30 37 2-s2.0-33646067433 10.1016/j.foodchem.2005.07.008
9. Bousquet P., Feldman J., Schwartz J., Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. Journal of Pharmacology and Experimental Therapeutics 1984 230 1 232 236 2-s2.0-0021153959 (Pubitemid 14097683)
10. 1 receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine. Journal of Hypertension 1997 15 2 117 125 2-s2.0-0030608948 10.1097/00004872-199715020- 00001 (Pubitemid 27116494)
11. 1-imidazoline receptors-definition, characterization, distribution, and transmembrane signaling. Annals of the New York Academy of Sciences 1995 763 22 42 2-s2.0-0028990748 10.1111/j.1749-6632.1995.tb32388.x
12. Morgan N. G., Chan S. L. F., Mourtada M., Monks L. K., Ramsden C. A., Imidazolines and pancreatic hormone secretion. Annals of the New York Academy of Sciences 1999 881 217 228 2-s2.0-0032799426 10.1111/j.1749-6632.1999.tb09364.x (Pubitemid 29349512)
13. 12 cells. Neuroscience Letters 2010 474 3 144 147 2-s2.0-77951499084 10.1016/j.neulet.2010.03.024
14. Chang C.-H., Wu H.-T., Cheng K.-C., Lin H.-J., Cheng J.-T., Increase of β -endorphin secretion by agmatine is induced by activation of imidazoline I 2 A receptors in adrenal gland of rats. Neuroscience Letters 2010 468 3 297 299 2-s2.0-72549092423 10.1016/j.neulet.2009.11.018
15. Dardonville C., Rozas I., Imidazoline binding sites and their ligands: an overview of the different chemical structures. Medicinal Research Reviews 2004 24 5 639 661 2-s2.0-3843115467 10.1002/med.20007 (Pubitemid 39038231)
16. Lee J.-P., Chen W., Wu H.-T., Lin K.-C., Cheng J.-T., Metformin can activate imidazoline I-2 receptors to lower plasma glucose in type 1-like diabetic rats. Hormone and Metabolic Research 2011 43 1 26 30 2-s2.0-78650959848 10.1055/s-0030-1267169
17. 1-receptor activation in high fat diet-fed mice. Evidence-Based Complementary and Alternative Medicine 2013 2013 7 589309 10.1155/2013/589309
18. Niu C.-S., Chen W., Wu H.-T., Cheng K.-C., Wen Y.-J., Lin K.-C., Cheng J.-T., Decrease of plasma glucose by allantoin, an active principle of yam (Dioscorea spp.), in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry 2010 58 22 12031 12035 2-s2.0-79952279110
19. Kahn L. P., Nolan J. V., Kinetics of allantoin metabolism in sheep. British Journal of Nutrition 2000 84 5 629 634 2-s2.0-0033673608
20. Pak N., Donoso G., Tagle M. A., Allantoin excretion in the rat. British Journal of Nutrition 1973 30 1 107 112 2-s2.0-0015876916
21. Koguchi T., Nakajima H., Wada M., Yamamoto Y., Innami S., Maekawa A., Tadokoro T., Dietary fiber suppresses elevations of uric acid and allantoin in serum and urine induced by dietary RNA and increases its excretion to feces in rats. Journal of Nutritional Science and Vitaminology 2002 48 3 184 193 2-s2.0-0036613887 (Pubitemid 34951162)
22. Seldinger S. I., Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiologica 2008 49 434 47 52 2-s2.0-56749098239 10.1080/02841850802133386
23. Ernsberger P., Giuliano R., Willette R. N., Reis D. J., Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. Journal of Pharmacology and Experimental Therapeutics 1990 253 1 408 418 2-s2.0-0025267255 (Pubitemid 20141529)
24. Hikasa Y., Masuda K., Asakura Y., Yamashita Y., Sato C., Kamio M., Miura A., Taniguchi T., Minamizuru N., Identification and characterization of platelet alpha2-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses. European Journal of Pharmacology 2013 720 363 375
25. 1-imidazoline receptors activation. Cardiovascular Therapeutics 2012 30 209 216 2-s2.0-79953265809 10.1111/j.1755-5922.2011.00269.x
26. Yang J., Wang W.-Z., Shen F.-M., Su D.-F., Cardiovascular effects of agmatine within the rostral ventrolateral medulla are similar to those of clonidine in anesthetized rats. Experimental Brain Research 2005 160 4 467 472 2-s2.0-12944326896 10.1007/s00221-004-2034-7 (Pubitemid 40174214)
27. 1-imidazoline receptors as targets of centrally acting antihypertensive drugs. Clinical pharmacology of moxonidine and rilmenidine. Annals of the New York Academy of Sciences 1999 881 420 429 2-s2.0-0032588760 10.1111/j.1749-6632.1999.tb09390.x (Pubitemid 29349537)
28. Colucci W. S., The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure. Clinical Cardiology 1998 21 12 I20 I24 2-s2.0-0031757052 (Pubitemid 28553939)
29. Jacob B. G., Richter W. O., Schwandt P., Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators. Fortschritte der Medizin 1993 111 8 126 129 2-s2.0-0027253695 (Pubitemid 23140402)
30. Hill M. A., Meininger G. A., Davis M. J., Laher I., Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends in Pharmacological Sciences 2009 30 7 363 374 2-s2.0-67649390994 10.1016/j.tips.2009.04.008
31. Yamazaki D., Tabara Y., Kita S., Hanada H., Komazaki S., Naitou D., Mishima A., Nishi M., Yamamura H., Yamamoto S., Kakizawa S., Miyachi H., Yamamoto S., Miyata T., Kawano Y., Kamide K., Ogihara T., Hata A., Umemura S., Soma M., Takahashi N., Imaizumi Y., Miki T., Iwamoto T., Takeshima H., TRIC-A channels in vascular smooth muscle contribute to blood pressure maintenance. Cell Metabolism 2011 14 2 231 241 2-s2.0-79960943895 10.1016/j.cmet.2011.05.011
32. Khalil R. A., Modulators of the vascular endothelin receptor in blood pressure regulation and hypertension. Current Molecular Pharmacology 2011 4 3 176 186 2-s2.0-80053539465 10.2174/1874467211104030176
33. Guinea G. V., Atienza J. M., Rojo F. J., García-Herrera C. M., Yiqun L., Claes E., Goicolea J. M., García-Montero C., Burgos R. L., Goicolea F. J., Elices M., Factors influencing the mechanical behaviour of healthy human descending thoracic aorta. Physiological Measurement 2010 31 12 1553 1565 2-s2.0-78650424847 10.1088/0967-3334/31/12/001
34. Thornfeldt C., Cosmeceuticals containing herbs: fact, fiction, and future. Dermatologic Surgery 2005 31 7 873 880 2-s2.0-23344438297
35. 1 receptors in animal and cell line. Hormone and Metabolic Research 2012 44 879 884